<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>464-RUFINAMIDE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="RUFINAMIDE" rxcui="69036">
<ATC code="N03AF03" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="COMBINED ESTROGEN-PROGESTIN CONTRACEPTIVES" code="G03AB-001" /></DRUG2>
<DESCRIPTION>Moderate decrease of the concentrations of ethinylestradiol</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Another contraceptive method, in particular a barrier type, should be used. </COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>464-RUFINAMIDE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="RUFINAMIDE" rxcui="69036">
<ATC code="N03AF03" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="VALPROIC (ACID) AND, BY EXTRAPOLATION, VALPROMIDE" code="N03AG0" /></DRUG2>
<DESCRIPTION>Possible increase of the concentrations of rufinamide, especially with children who weigh less than 30 kg.</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>With children who weigh less than 30 kg: do not exceed the total dose of 600mg/day after the period of titration. </COMMENT>
</INTERACTION>
</INTERACTIONS>
